mnc NEWS
Research

The benefit curve for daily steps flattens far earlier than 10,000

A pooled analysis of 27 cohort studies found most of the reduction in mortality risk arrives between 2,000 and 7,000 steps a day. The famous target came from a 1960s marketing campaign.

  • Most of the measured risk reduction occurs between about 2,400 and 7,000 steps
  • Additional benefit above 8,000 steps was small and statistically uncertain
  • Pace mattered independently of total count
A paved path through a city park in the morning.
A paved path through a city park in the morning.Notafly / Wikimedia Commons

A pooled analysis of 27 cohort studies, together following about 226,000 adults, has produced a dose-response curve for daily steps that looks nothing like the round number most people aim for.

The steepest part of the curve sits between roughly 2,400 and 7,000 steps a day. Moving from the lowest quartile to about 7,000 was associated with the large majority of the observed reduction in all-cause mortality risk. Above about 8,000, additional steps were associated with further small reductions that were not statistically robust in most of the contributing studies.

Where 10,000 came from

The 10,000-step target has no clinical origin. It is generally traced to a Japanese pedometer marketed in the 1960s whose name translated roughly as “ten-thousand-step meter,” chosen because the figure was memorable and the character resembled a walking person.

That does not make it a bad target. It makes it an arbitrary one, and arbitrary targets discourage people who cannot reach them. The finding that matters clinically is that someone currently walking 2,000 steps gains far more by reaching 5,000 than someone at 8,000 gains by reaching 11,000.

If you are at three thousand steps, the most valuable walking you will ever do is the next two thousand.— An epidemiologist who contributed to the pooled analysis

Pace, and the limits of this evidence

Cadence mattered independently. Adults whose steps included at least thirty minutes at a brisk pace showed additional risk reduction at the same total count, suggesting intensity contributes something beyond volume.

The important limitation is that these are observational cohorts. People who walk more differ from people who walk less in many ways — health status, income, neighborhood safety, whether illness is already limiting them. The studies adjust for what they can measure, and reverse causation cannot be fully excluded.

A paved path through a city park in the morning.
A paved path through a city park in the morning.Notafly / Wikimedia Commons
  • Pooled analysis: 27 cohorts, about 226,000 adults
  • Steepest benefit: roughly 2,400 to 7,000 steps a day
  • Above 8,000: small and statistically uncertain additional benefit
  • Cadence: at least 30 minutes at a brisk pace added benefit at the same total

This is a summary of published research and is not medical advice. Anyone starting or changing an exercise routine, particularly with an existing heart or joint condition, should discuss it with a clinician first.

3,620 comments 12,410 shares Health

Read nextShow More

Comments3,620

0 / 500
  • L
    Laura M.Austin, TX1 hour ago

    You do not see many pieces that show the reporting process like this anymore.

  • L
    Laura M.Tampa, FLYesterday

    You do not see many pieces that show the reporting process like this anymore.

  • L
    Laura M.Portland, OR1 hour ago

    Clearly written, and the section on the numbers is more careful than most coverage of this.

  • L
    Laura M.Buffalo, NYYesterday

    I had not thought about it from this angle. It shifted my view a little.

  • L
    Laura M.St. Louis, MO1 hour ago

    Hope there is a follow-up. These stories tend to drop out of view after a few weeks.

Back to top